Title: Targeting of protein ERGIC-53 to the ER/ERGIC/cis-Golgi recycling pathway Document date: 1995_10_1
ID: 7oklz2ch_27
Snippet: COS cells transfected with GM, L53T4C53 and L53T4R2AI0 were pulsed for five min with [35S]methionine and chased for up to 2 h. The immunoprecipitated mutant proteins were digested with endo H and the fraction of resistant protein determined (Fig. 4 a) . G M representing overexpressed wild-type ERGIC-53 showed ~10% endo H resistance after 1 h of chase (Fig. 4 a) . This value was identical to that obtained with an ERGIC-53 mutant containing the N-g.....
Document: COS cells transfected with GM, L53T4C53 and L53T4R2AI0 were pulsed for five min with [35S]methionine and chased for up to 2 h. The immunoprecipitated mutant proteins were digested with endo H and the fraction of resistant protein determined (Fig. 4 a) . G M representing overexpressed wild-type ERGIC-53 showed ~10% endo H resistance after 1 h of chase (Fig. 4 a) . This value was identical to that obtained with an ERGIC-53 mutant containing the N-glycosylation site but no epitope tag (not shown). The replacement of the transmembrane domain in ERGIC-53 by CD4 (L53T4C53) did not change the acquisition of endo H resistance, suggesting that it is not required for targeting (Fig. 4 a) . The inverse construct with the ERGIC-53 transmembrane domain in a CD4 background IAT53C4 showed similar kinetics of endo H resistance (Fig. 4b) and comparable localization by immunofluorescence (not shown) as overexpressed wild type CD4. This indicated that the transmembrane domain of ERGIC-53 was not sufficient for the targeting of ERGIC-53. Substitution of both the transmembrane and the cytoplasmic domains (L53T4R2A10) resulted in ~50% endo H resistance after 1 h of chase (Fig. 4 a) . The lumenal domain of ER-GIC-53 is not sufficient for targeting.
Search related documents:
Co phrase search for related documents- COS cell and lumenal domain: 1
- COS cell and mutant protein: 1
- COS cell and transmembrane domain: 1, 2
- COS cell and transmembrane domain construct: 1
- COS cell and wild type: 1, 2, 3
- cytoplasmic domain and ER lumenal domain: 1
- cytoplasmic domain and lumenal domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cytoplasmic domain and min pulse: 1
- cytoplasmic domain and mutant protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cytoplasmic domain and transmembrane domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- cytoplasmic domain and transmembrane domain construct: 1, 2
Co phrase search for related documents, hyperlinks ordered by date